Insights

Strategic partnerships Enko has a track record of collaboration with major ag players (Syngenta, Nufarm) and high-profile investors (Gates Foundation, Anterra, Finistere). This creates strong opening for co-development deals, licensing opportunities, or joint ventures to advance new crop protection solutions.

AI driven discovery The company emphasizes applying drug discovery approaches and machine learning to agriculture, signaling clear opportunities to position Enko for AI powered discovery services, data licensing, and platform collaborations to accelerate time to market for pesticides and fungicides.

Global expansion signals Recent announcements around novel chemistry discovery and international partnerships indicate growth and scale potential. Sales conversations can target multinational ag retailers, crop protection distributors, and regional grower alliances seeking innovative, faster R&D pipelines.

Sustainability focus Enko’s mission to design safe and sustainable crop solutions aligns with customer demand for eco-friendly products and regulatory-friendly formulations, presenting opportunities in certifications, sustainability programs, and premium product avenues with compliant profiles.

Funding and credibility Significant funding rounds and board additions (including Tim Hassinger) bolster credibility for large-scale deals, enabling sales teams to pursue larger pilot programs, strategic investments, and multi-year supply or licensing agreements with confidence.

Enko® Tech Stack

Enko® uses 8 technology products and services including html5media, Docker, Cloudflare, and more. Explore Enko®'s tech stack below.

  • html5media
    Audio, Video, Graphics
  • Docker
    Containerization
  • Cloudflare
    Content Management System
  • Microsoft Excel
    Editors
  • Microsoft Exchange Online Protection
    Email Security
  • scikit-learn
    Machine Learning
  • LinkedIn
    Online Community Software
  • HSTS
    Security

Media & News

Enko®'s Email Address Formats

Enko® uses at least 2 format(s):
Enko® Email FormatsExamplePercentage
First_Last@enko.agJohn_Doe@enko.ag
100%
First.Last@enkochem.comJohn.Doe@enkochem.com
98%
Fir.Last@enkochem.comJoh.Doe@enkochem.com
2%

Frequently Asked Questions

What is Enko®'s stock symbol?

Minus sign iconPlus sign icon
Enko® is a publicly traded company; the company's stock symbol is CNKS.L.

What is Enko®'s official website and social media links?

Minus sign iconPlus sign icon
Enko®'s official website is enko.ag and has social profiles on LinkedIn.

How much revenue does Enko® generate?

Minus sign iconPlus sign icon
As of July 2026, Enko®'s annual revenue is estimated to be $10M - $25M.

What is Enko®'s SIC code NAICS code?

Minus sign iconPlus sign icon
Enko®'s SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Enko® have currently?

Minus sign iconPlus sign icon
As of July 2026, Enko® has approximately 56 employees across 3 continents, including North AmericaEuropeSouth America. Key team members include Chief Executive Officer: A. K.Vice President Finance: S. P. S.Company Owner: A. P.. Explore Enko®'s employee directory with LeadIQ.

What industry does Enko® belong to?

Minus sign iconPlus sign icon
Enko® operates in the Biotechnology Research industry.

What technology does Enko® use?

Minus sign iconPlus sign icon
Enko®'s tech stack includes html5mediaDockerCloudflareMicrosoft ExcelMicrosoft Exchange Online Protectionscikit-learnLinkedInHSTS.

What is Enko®'s email format?

Minus sign iconPlus sign icon
Enko®'s email format typically follows the pattern of First_Last@enko.ag. Find more Enko® email formats with LeadIQ.

How much funding has Enko® raised to date?

Minus sign iconPlus sign icon
As of July 2026, Enko® has raised $135M in funding. The last funding round occurred on Jan 31, 2023.

When was Enko® founded?

Minus sign iconPlus sign icon
Enko® was founded in 2017.
Enko® logo

Enko®

Biotechnology ResearchConnecticut, United States51-200 Employees

Enko is a biotechnology research company that designs safe and sustainable solutions to protect crops from threats such as pests and diseases. By adapting drug discovery and development approaches from pharma to plants, it aims to accelerate the discovery and deployment of crop protection, offering an innovation model intended to meet evolving farming needs.

Section iconCompany Overview

Website
enko.ag
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
CNKS.L
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2017
Employees
51-200

Section iconFunding & Financials

  • $135M

    Enko® has raised a total of $135M of funding over 5 rounds. Their latest funding round was raised on Jan 31, 2023as a series_c.

  • $10M - $25M

    Enko®'s revenue is estimated to be in the range of $10M - $25M

Section iconFunding & Financials

  • $135M

    Enko® has raised a total of $135M of funding over 5 rounds. Their latest funding round was raised on Jan 31, 2023as a series_c.

  • $10M - $25M

    Enko®'s revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.